Nagai Noriaki, Yamamoto Tetsushi, Tanabe Wataru, Ito Yoshimasa, Kurabuchi Satoshi, Mitamura Kuniko, Taga Atsushi
Faculty of Pharmacy, Kinki University.
J Oleo Sci. 2015;64(3):331-5. doi: 10.5650/jos.ess14075. Epub 2015 Feb 9.
We investigate whether maple syrup is a suitable sweetener in the management of type 2 diabetes using the Otsuka Long-Evans Tokushima Fatty (OLETF) rat. The enhancement in plasma glucose (PG) and glucose absorption in the small intestine were lower after the oral administration of maple syrup than after sucrose administration in OLETF rats, and no significant differences were observed in insulin levels. These data suggested that maple syrup might inhibit the absorption of glucose from the small intestine and preventing the enhancement of PG in OLETF rats. Therefore, maple syrup might help in the prevention of type 2 diabetes.
我们使用大冢长- Evans 德岛肥胖（OLETF）大鼠研究枫糖浆是否是 2 型糖尿病管理中合适的甜味剂。在 OLETF 大鼠中，口服枫糖浆后血浆葡萄糖（PG）的升高和小肠中葡萄糖的吸收低于口服蔗糖后，并且胰岛素水平未观察到显著差异。这些数据表明，枫糖浆可能抑制小肠中葡萄糖的吸收并防止 OLETF 大鼠中 PG 的升高。因此，枫糖浆可能有助于预防 2 型糖尿病。
